|Articles|August 1, 2016
- Pharmaceutical Executive-08-01-2016
- Volume 36
- Issue 8
Pharmaceutical Executive, August 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Pharm Exec's 15th Annual Industry Auditalmost 10 years ago
The Industry Audit: Fifteen Years Rightalmost 10 years ago
Dealmaking in 2016: It’s Complicatedalmost 10 years ago
Steady Hands: AmerisourceBergen's Peyton Howellalmost 10 years ago
Drug Shortages Raise Economic and Ethical Challengesalmost 10 years ago
The ‘Cure’-All for 21st Century Data Sharingalmost 10 years ago
European Pharma and the Unified Patent Courtalmost 10 years ago
An EU Referendum ... on Drug Pricing?almost 10 years ago
Country Report: HungaryAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
2
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
3
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
4
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
5